Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 162.11%4B | -52.57%1.52B | 23.05%3.21B | -37.58%2.61B | 28.59%4.18B | 43.36%3.25B | -50.70%2.27B | 42.03%4.6B | 3.24B | 100.91%2.39B |
Net profit before non-cash adjustment | -7.62%2.72B | 10.92%2.94B | 18.21%2.65B | -17.56%2.25B | -23.05%2.72B | -7.49%3.54B | 24.76%3.83B | -0.75%3.07B | --3.09B | -5.50%1.57B |
Total adjustment of non-cash items | 187.42%927.3M | -328.81%-1.06B | -10.60%463.63M | 109.03%518.59M | 168.42%248.1M | 24.23%-362.63M | -593.45%-478.58M | -77.57%96.99M | --432.4M | -27.73%169.35M |
-Depreciation and amortization | 17.70%195.62M | 3.53%166.2M | -17.29%160.52M | -1.23%194.07M | -17.26%196.48M | -9.29%237.47M | 5.08%261.79M | -9.95%249.13M | --276.67M | -8.15%166.78M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -42.57%27.72M |
-Disposal profit | 100.32%1.66M | -144,185.71%-515.1M | ---357K | ---- | -121.47%-733K | 109.40%3.41M | -436.06%-36.33M | 96.51%-6.78M | ---194.25M | --0 |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --159.8M | ---- |
-Other non-cash items | 202.55%730.02M | -334.59%-711.9M | -6.49%303.46M | 519.97%324.52M | 108.67%52.34M | 14.28%-603.52M | -384.31%-704.04M | -176.44%-145.37M | --190.18M | -2,295.90%-25.16M |
Changes in working capital | 196.52%347.36M | -479.85%-359.89M | 161.86%94.75M | -112.65%-153.16M | 1,495.78%1.21B | 107.04%75.9M | -174.96%-1.08B | 610.84%1.44B | ---281.69M | 193.49%655.8M |
-Change in receivables | -281.56%-2.44B | -62.30%-640M | 69.69%-394.34M | -135.20%-1.3B | 721.87%3.7B | 57.36%-594.33M | -202.84%-1.39B | 26.29%-460.26M | ---624.41M | 88.88%-209.81M |
-Change in inventory | 135.98%230.82M | -338.05%-641.54M | -7.53%269.5M | 235.08%291.46M | 66.86%-215.76M | -278.37%-651.13M | 196.36%365.05M | -159.51%-378.83M | --636.61M | -498.01%-325.12M |
-Change in payables | 177.60%2.56B | 319.72%921.66M | -74.36%219.59M | 137.74%856.29M | -271.72%-2.27B | 2,752.36%1.32B | -102.19%-49.82M | 875.14%2.28B | ---293.9M | 16.04%1.25B |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 63.99%-24.3M |
-Changes in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -141.76%-38.02M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -750.00%-51K | 95.45%-6K | -132K | 80.64%-236K | ||||||
Interest received (cash flow from operating activities) | 6.69%2.2M | 52.36%2.06M | -48.00%1.35M | 3.99%2.6M | 61.97%2.5M | -18.37%1.55M | 145.97%1.89M | -86.47%770K | 5.69M | 6.67%4.65M |
Tax refund paid | 11.77%-953.74M | -82.45%-1.08B | 22.39%-592.51M | 20.99%-763.47M | -0.13%-966.26M | -4.04%-964.98M | 23.85%-927.5M | -27.91%-1.22B | -952.23M | -10.19%-658.11M |
Other operating cash inflow (outflow) | 80.00%-13K | -6,600.00%-65K | 1K | 0 | -1K | 0 | 0.00%-2K | -2K | 0 | 0.00%-1K |
Operating cash flow | 583.71%3.04B | -83.02%445.15M | 41.69%2.62B | -42.52%1.85B | 40.60%3.22B | 70.42%2.29B | -60.32%1.34B | 47.58%3.39B | --2.29B | 191.49%1.74B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 48.20%-502.58M | 64.83%-970.31M | -134.48%-2.76B | -990.90%-1.18B | -17.97%-107.86M | 54.01%-91.42M | -57.15%-198.79M | 46.25%-126.5M | ---235.36M | 9.51%-127.63M |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -65.14%-134.39M |
Net business purchase and sale | 129.77%150.34M | ---505.08M | --0 | ---- | ---- | 1.56%613.72M | --604.27M | ---- | ---- | ---- |
Net investment product transactions | --0 | --180.11M | --0 | --0 | --0 | -1,878.08%-4.99B | --280.66M | ---- | --488.42M | -2,003.88%-460.45M |
Net changes in other investments | -95.87%132.76M | 2,462.16%3.21B | -35.80%-135.97M | -876.75%-100.12M | 176.26%12.89M | -121.44%-16.9M | 5,176.63%78.84M | -103.42%-1.55M | --45.48M | 31.83%-1.52M |
Investing cash flow | -111.45%-219.47M | 166.21%1.92B | -126.75%-2.89B | -1,244.41%-1.28B | 97.88%-94.97M | -686.28%-4.48B | 697.38%764.97M | -142.89%-128.05M | --298.53M | -261.16%-723.99M |
Financing cash flow | ||||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 43.53%-41M |
Net common stock issuance | ---- | ---- | ---298.08M | --0 | ---- | ---- | ---- | ---- | ---- | 99.93%-45K |
Cash dividends paid | -42.86%-1.42B | -1.91%-994.69M | -3.03%-976.08M | -3.12%-947.37M | -10.34%-918.66M | -11.54%-832.54M | -26.83%-746.42M | -7.89%-588.52M | ---545.46M | -11.09%-341.69M |
Net other fund-raising expenses | 85.64%-24.15M | -7,696.94%-168.18M | ---2.16M | ---- | ---- | 80.25%-32K | ---162K | ---- | ---64K | ---1K |
Financing cash flow | -24.27%-1.45B | 8.89%-1.16B | -34.72%-1.28B | -3.12%-947.37M | -10.34%-918.66M | -11.52%-832.57M | -26.86%-746.58M | -7.88%-588.52M | ---545.52M | 13.29%-382.73M |
Net cash flow | ||||||||||
Beginning cash position | 11.34%11.77B | -12.78%10.57B | -2.99%12.12B | 21.44%12.5B | -22.73%10.29B | 11.39%13.32B | 28.75%11.95B | 28.29%9.29B | --7.24B | -1.14%3.98B |
Current changes in cash | 15.02%1.38B | 177.39%1.2B | -314.68%-1.55B | -116.93%-373.58M | 172.87%2.21B | -322.26%-3.03B | -48.97%1.36B | 30.38%2.67B | --2.05B | 1,480.19%630.97M |
Cash adjustments other than cash changes | ---- | ---- | 0.00%-1K | ---1K | ---- | ---- | 0.00%1K | --1K | ---- | 0.00%-1K |
End cash Position | 11.71%13.15B | 11.34%11.77B | -12.78%10.57B | -2.99%12.12B | 21.44%12.5B | -22.73%10.29B | 11.39%13.32B | 28.75%11.95B | --9.29B | 15.85%4.61B |
Free cash flow | 583.84%2.54B | -283.62%-525.17M | -120.31%-136.9M | -78.34%673.91M | 41.54%3.11B | 92.03%2.2B | -64.87%1.14B | 58.30%3.26B | --2.06B | 294.86%1.48B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |